ATE326970T1 - Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen - Google Patents
Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomenInfo
- Publication number
- ATE326970T1 ATE326970T1 AT03742638T AT03742638T ATE326970T1 AT E326970 T1 ATE326970 T1 AT E326970T1 AT 03742638 T AT03742638 T AT 03742638T AT 03742638 T AT03742638 T AT 03742638T AT E326970 T1 ATE326970 T1 AT E326970T1
- Authority
- AT
- Austria
- Prior art keywords
- seminomas
- ylamino
- ylmethyl
- methyl
- treatment
- Prior art date
Links
- 201000010208 Seminoma Diseases 0.000 title abstract 2
- GTKIGDZXPDCIKR-UHFFFAOYSA-N 2-phenylbenzamide Chemical compound NC(=O)C1=CC=CC=C1C1=CC=CC=C1 GTKIGDZXPDCIKR-UHFFFAOYSA-N 0.000 title 1
- -1 PYRIMIDINE-2-YLAMINO Chemical class 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35904902P | 2002-02-22 | 2002-02-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326970T1 true ATE326970T1 (de) | 2006-06-15 |
Family
ID=27757766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03742638T ATE326970T1 (de) | 2002-02-22 | 2003-02-17 | Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050153975A1 (de) |
| EP (1) | EP1487452B1 (de) |
| JP (1) | JP2005523282A (de) |
| AT (1) | ATE326970T1 (de) |
| AU (1) | AU2003209521A1 (de) |
| DE (1) | DE60305460D1 (de) |
| WO (1) | WO2003070248A1 (de) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW225528B (de) * | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
| CO4940418A1 (es) * | 1997-07-18 | 2000-07-24 | Novartis Ag | Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso |
| KR100681724B1 (ko) * | 1999-10-19 | 2007-02-28 | 머크 앤드 캄파니 인코포레이티드 | 티로신 키나제 억제제 및 이를 포함하는 약제학적 조성물 |
| MY128449A (en) * | 2000-05-24 | 2007-02-28 | Sugen Inc | Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| US20020077301A1 (en) * | 2000-10-05 | 2002-06-20 | Whitehead Institute For Biomedical Research | Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors |
-
2003
- 2003-02-17 EP EP03742638A patent/EP1487452B1/de not_active Expired - Lifetime
- 2003-02-17 AU AU2003209521A patent/AU2003209521A1/en not_active Abandoned
- 2003-02-17 JP JP2003569204A patent/JP2005523282A/ja active Pending
- 2003-02-17 DE DE60305460T patent/DE60305460D1/de not_active Expired - Lifetime
- 2003-02-17 AT AT03742638T patent/ATE326970T1/de not_active IP Right Cessation
- 2003-02-17 WO PCT/IB2003/000622 patent/WO2003070248A1/en not_active Ceased
- 2003-02-17 US US10/504,896 patent/US20050153975A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005523282A (ja) | 2005-08-04 |
| DE60305460D1 (de) | 2006-06-29 |
| EP1487452B1 (de) | 2006-05-24 |
| US20050153975A1 (en) | 2005-07-14 |
| AU2003209521A1 (en) | 2003-09-09 |
| WO2003070248A1 (en) | 2003-08-28 |
| EP1487452A1 (de) | 2004-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60118430D1 (de) | Behandlung gastrointestinaler stroma-tumoren | |
| MY128664A (en) | Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use | |
| IL164678A (en) | High-drug tablet containing 4– (4-methylpiprazine – 1-ylamethyl) -n - [(4-methyl-3– (4-pyridin-3-il) pyrimidine-2-ylamino) phenyl] -benzamide or compatible salt Its pharmaceutical and process for its preparation | |
| TWI347186B (en) | Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide | |
| ATE399555T1 (de) | Behandlung der rheumatoiden arthritis mit imitanib | |
| BR0316126A (pt) | Combinação de compostos para o tratamento de leucemia linfocìtica crÈnica | |
| DE60305460D1 (de) | Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen | |
| DE602004022540D1 (de) | Verwendung von tyrosin-kinase-hemmern zur behandlung von diabetes | |
| BR0312242A (pt) | 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil]-benzamida para o tratamento da fibrose pulmonar | |
| WO2004026930A3 (en) | The method for reducing inflammation using sti-571 or its salt | |
| WO2004103374A3 (en) | Imatinib combinations for head and neck cancers | |
| HK1097535A (en) | Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide | |
| UY28498A1 (es) | Modificación de cristal de un derivado de n-fenil-2-pirimidinamina, procesos para su fabricación y su uso. | |
| ECSP982588A (es) | Modificacion de cristal de un derivado de n-fenil -2-pirimidinamina procesos para su fabricacion y su uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |